| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 157, Issue 5 1944-1950, Copyright © 1996 by American Association of Immunologists
ARTICLES |
K Onodera, M Lehmann, E Akalin, HD Volk, MH Sayegh and JW Kupiec-Weglinski
Harvard Medical School, Surgical Research Laboratory, Boston, MA 02115, USA.
LBNF1 heart grafts are rejected in an accelerated manner within 36 h by LEW rats that have been sensitized with Brown Norway rat skin grafts on day -7. Treatment with RIB-5/2, a CD4-nondepleting mAb (10 doses of 5 mg/rat/day, i.v., from day -7 to day +21) abrogated rejection at <36 h and produced indefinite (>200 days) cardiac allograft survival. Transplantation tolerance in this model developed within several weeks, and during the maintenance phase (>100 days) it was associated with diminished host circulating allo-Ab responses and induction of peripheral allospecific T cell unresponsiveness both in vitro and in vivo. Tolerant cells in mAb-treated hosts could disable naive or alloimmune cells, so that they failed to trigger graft rejection. Moreover, donor-specific and organ-nonspecific tolerance could be adoptively transferred by spleen cells alone into new sets of primary (100%) and secondary (>40%) test recipients. CD4+ T cells were instrumental for the induction of such readily transferable tolerance. The first and second generation suppressive regulatory cells were also critical for the inhibition of allograft recognition by normal or even alloimmune cells. Hence, the features of an "infectious" tolerance pathway to minor histocompatibility-mismatched skin grafts, originally described in thymectomized mice, may be applied to the euthymic primed rats rendered tolerant to fully MHC-incompatible vascularized organ allografts. Such reprogramming of host cell-mediated regulatory mechanisms following CD4-targeted therapy adds to our appreciation of the potential utility and applicability of infectious tolerance in transplant recipients treated with a perioperative course of CD4- targeted monotherapy.
This article has been cited by other articles:
|
|
 |
|
  M. Hu, D. Watson, G. Y. Zhang, N. Graf, Y. M. Wang, M. Sartor, B. Howden, J. Fletcher, and S. I. Alexander Long-Term Cardiac Allograft Survival across an MHC Mismatch after "Pruning" of Alloreactive CD4 T Cells J. Immunol., May 15, 2008; 180(10): 6593 - 6603. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Schumacher, P. O. Wafula, A. Z. Bertoja, A. Sollwedel, C. Thuere, I. Wollenberg, H. Yagita, H.-D. Volk, and A. C. Zenclussen Mechanisms of Action of Regulatory T Cells Specific for Paternal Antigens During Pregnancy Obstet. Gynecol., November 1, 2007; 110(5): 1137 - 1145. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Wang, J. Arp, X. Huang, W. Liu, S. Ramcharran, J. Jiang, B. Garcia, N. Kanai, W. Min, P. J. O'Connell, et al. Distinct Subsets of Dendritic Cells Regulate the Pattern of Acute Xenograft Rejection and Susceptibility to Cyclosporine Therapy J. Immunol., March 15, 2006; 176(6): 3525 - 3535. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Kitade, M. Kawai, O. Rutgeerts, W. Landuyt, M. Waer, C. Mathieu, and J. Pirenne Early Presence of Regulatory Cells in Transplanted Rats Rendered Tolerant by Donor-Specific Blood Transfusion J. Immunol., October 15, 2005; 175(8): 4963 - 4970. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Winsor-Hines, C. Merrill, M. O'Mahony, P. E. Rao, S. P. Cobbold, H. Waldmann, D. J. Ringler, and P. D. Ponath Induction of Immunological Tolerance/Hyporesponsiveness in Baboons with a Nondepleting CD4 Antibody J. Immunol., October 1, 2004; 173(7): 4715 - 4723. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. J. Grazia, B. A. Pietra, Z. A. Johnson, B. P. Kelly, R. J. Plenter, and R. G. Gill A Two-Step Model of Acute CD4 T-Cell Mediated Cardiac Allograft Rejection J. Immunol., June 15, 2004; 172(12): 7451 - 7458. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Wang, K. A. Hosiawa, W. Min, J. Yang, X. Zhang, B. Garcia, T. E. Ichim, D. Zhou, D. Lian, D. J. Kelvin, et al. Cytokines Regulate the Pattern of Rejection and Susceptibility to Cyclosporine Therapy in Different Mouse Recipient Strains After Cardiac Allografting J. Immunol., October 1, 2003; 171(7): 3823 - 3836. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Kataoka, J. A. Margenthaler, G. Ku, and M. W. Flye Development of Infectious Tolerance After Donor-Specific Transfusion and Rat Heart Transplantation J. Immunol., July 1, 2003; 171(1): 204 - 211. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Noris, D. Cugini, F. Casiraghi, N. Azzollini, L. D. D. V. Moraes, M. Mister, A. Pezzotta, R. A. Cavinato, S. Aiello, N. Perico, et al. Thymic Microchimerism Correlates with the Outcome of Tolerance-Inducing Protocols for Solid Organ Transplantation J. Am. Soc. Nephrol., December 1, 2001; 12(12): 2815 - 2826. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Yamada, A. Chandraker, T. M. Laufer, A. J. Gerth, M. H. Sayegh, and H. Auchincloss Jr. Cutting Edge: Recipient MHC Class II Expression Is Required to Achieve Long-Term Survival of Murine Cardiac Allografts After Costimulatory Blockade J. Immunol., November 15, 2001; 167(10): 5522 - 5526. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Zhai, X.-D. Shen, M. Lehmann, R. Busuttil, H.-D. Volk, and J. W. Kupiec-Weglinski T Cell Subsets and In Vitro Immune Regulation in ""Infectious"" Transplantation Tolerance J. Immunol., November 1, 2001; 167(9): 4814 - 4820. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. C. Wiseman, B. A. Pietra, B. P. Kelly, G. R. Rayat, M. Rizeq, and R. G. Gill Donor IFN-{gamma} Receptors Are Critical for Acute CD4+ T Cell-Mediated Cardiac Allograft Rejection J. Immunol., November 1, 2001; 167(9): 5457 - 5463. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. H. Hammer, Y. Zhai, M. Katori, T. Ritter, H.-D. Volk, A. J. Coito, and J. W. Kupiec-Weglinski Homing of In Vitro-Generated Donor Antigen-Reactive CD4+ T Lymphocytes to Renal Allografts Is {{alpha}}4{beta}1 But Not {{alpha}}L{beta}2 Integrin Dependent J. Immunol., January 1, 2001; 166(1): 596 - 601. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J. Coito, K. Onodera, H. Kato, R. W. Busuttil, and J. W. Kupiec-Weglinski Fibronectin-Mononuclear Cell Interactions Regulate Type 1 Helper T Cell Cytokine Network in Tolerant Transplant Recipients Am. J. Pathol., October 1, 2000; 157(4): 1207 - 1218. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Ke, T. Ritter, H. Kato, Y. Zhai, J. Li, M. Lehmann, R. W. Busuttil, H.-D. Volk, and J. W. Kupiec-Weglinski Regulatory Cells Potentiate the Efficacy of IL-4 Gene Transfer by Up-Regulating Th2-Dependent Expression of Protective Molecules in the Infectious Tolerance Pathway in Transplant Recipients J. Immunol., June 1, 2000; 164(11): 5739 - 5745. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. J. P. M. Koenen and I. Joosten Blockade of CD86 and CD40 induces alloantigen-specific immunoregulatory T cells that remain anergic even after reversal of hyporesponsiveness Blood, May 15, 2000; 95(10): 3153 - 3161. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Honey, S. P. Cobbold, and H. Waldmann CD40 Ligand Blockade Induces CD4+ T Cell Tolerance and Linked Suppression J. Immunol., November 1, 1999; 163(9): 4805 - 4810. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Coulombe, H. Yang, L. A. Wolf, and R. G. Gill Tolerance to Antigen-Presenting Cell-Depleted Islet Allografts Is CD4 T Cell Dependent J. Immunol., March 1, 1999; 162(5): 2503 - 2510. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. A. ROSSINI, D. L. GREINER, and J. P. MORDES Induction of Immunologic Tolerance for Transplantation Physiol Rev, January 1, 1999; 79(1): 99 - 141. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. M. Hall, L. Fava, J. Chen, K. M. Plain, R. A. Boyd, S. T. Spicer, and M. F. Berger Anti-CD4 Monoclonal Antibody-Induced Tolerance to MHC-Incompatible Cardiac Allografts Maintained by CD4+ Suppressor T Cells That Are Not Dependent upon IL-4 J. Immunol., November 15, 1998; 161(10): 5147 - 5156. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Onodera, H.-D. Volk, T. Ritter, and J. W. Kupiec-Weglinski Thymus Requirement and Antigen Dependency in the ""Infectious"" Tolerance Pathway in Transplant Recipients J. Immunol., June 15, 1998; 160(12): 5765 - 5772. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
